Latest Trials


EudraCT Number: 2004-002143-27 Sponsor Protocol Number: 1208.15 Start Date: 2005-02-15
Sponsor Name: Boehringer Ingelheim Austria GmbH
Full Title: A double-blind, stratified, randomised, parallel, placebo-controlled, multi-centre study to compare the efficacy and safety of duloxetine hydrochloride (40mg twice a day) and tolterodine tartrate (...
Medical condition: Urge Urinary Incontinence (UUI)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: AT (Completed) DK (Prematurely Ended) SE (Completed) DE (Completed)
Trial results: View results
3
Subscribe